Endometriosis has six treatment options. Only one removes the disease itself.
That is not a framing choice. It is a biological fact. Excision surgery physically removes endometriosis lesions from the body. Hormonal suppression masks symptoms while lesions remain. Ablation burns the visible surface while deeper disease stays in place. Hysterectomy removes an organ but leaves extrauterine implants untouched. IVF bypasses the disease entirely. Watchful waiting does nothing to the disease at all.
For women searching for the best treatment for endometriosis, whether the goal is symptom relief, fertility, or both, the answer depends on understanding this distinction: disease-directed treatment versus symptom management. This guide covers all six approaches, what each one does and does not do, and what the evidence shows. Cross-links to the endometriosis condition guide, fertility-preserving surgery, and NaProTechnology versus IVF are included where relevant.
Endometriosis treatment options at a glance
Six approaches, summarized. Only excision removes the disease itself; the others manage symptoms, bypass the disease, or remove an organ. Each evidence cell links to the source.
| Approach | What it does | Fertility impact | Evidence |
|---|---|---|---|
| Excision surgery (laparoscopic) | Removes endometriosis lesions by sharp dissection down to healthy tissue. Disease-modifying: eliminates the actual lesions and restores distorted pelvic anatomy. Specimen sent for pathologic confirmation. | Fertility-restoring for many. A 65.8% postoperative pregnancy rate in stage III/IV patients; laparoscopic access outperformed open surgery (74.3% vs 61.3%). Ovarian endometrioma cystectomy can lower ovarian reserve, so technique and timing matter. | Yeung 2011: zero histologic recurrence at repeat surgery without postoperative hormones. Schippert 2020: 93.2% complete or partial symptom relief; 21.8% recurrence in stage III/IV. |
| Ablation / fulguration | Thermal destruction of the visible surface of endometriosis implants. Does not cut lesions out or confirm clearance below the surface. Faster and technically less demanding than excision, but leaves deeper disease behind. | Less favorable than excision. Residual deep disease and anatomy distortion can persist after ablation. Because excision removes more disease, it also yields greater fertility benefit than surface burning. | Yeung 2011: zero histologic recurrence after complete excision, without postoperative hormones. Recurrence and persistence after ablation are substantially higher than after excision; for superficial disease, short-term pain outcomes are broadly similar, with excision favored for deep or recurrent disease and for tissue diagnosis. |
| Hormonal suppression (GnRH agonists/antagonists, combined hormonal contraceptives, progestins) | Suppresses estrogen or opposes it to reduce endometriosis-associated pain. Manages symptoms; does not eliminate lesions. Disease and symptoms typically return after stopping. | Not a fertility treatment. These medications suppress ovulation and are incompatible with conception while in use. They offer no fertility benefit for couples actively trying to conceive and can delay treatment that actually addresses the disease. | Surrey 2023: GnRH agonists effective for symptoms but disease recurs after stopping; 53.4% symptom recurrence at 5 years after GnRH therapy, higher in severe disease. |
| IVF | Bypasses endometriosis by retrieving eggs and transferring embryos. Does not remove disease or address the pelvic environment. Disease and pain persist after IVF. | Can achieve pregnancy but with reduced success rates in stage III/IV disease: lower implantation rates, lower clinical pregnancy rates, higher cancellation rates. Carries elevated obstetric risk. <a href="/library/assisted-reproductive-technology-and-the-risk-of-preeclampsia-an-updated-systema-reccpdeshwwxvgzwt/">Almasi-Hashiani et al. (2019)</a> found a 1.71-fold higher preeclampsia risk versus natural conception. | Coccia 2022: endometriosis reduces oocyte yield and implantation in advanced disease. Boyle 2025: RRM matched single-cycle IVF live-birth rates with fewer multiples, preterm births, and low-birth-weight babies. |
| Hysterectomy | Removes the uterus (sometimes ovaries). Does not cure endometriosis because the disease exists outside the uterus. Extrauterine implants remain after surgery and symptoms can persist or recur. Ends fertility permanently. | Ends fertility. Appropriate only when childbearing is complete and symptoms are severe and refractory, and only when all extrauterine disease is excised concurrently. | Hysterectomy does not cure endometriosis because the disease is extrauterine. (Whittaker NM, Endometriosis Masterclass) The disease-clearing mechanism is excision of lesions, not removal of the organ. |
| Watchful waiting / pain management (NSAIDs, expectant) | No active disease-directed treatment. NSAIDs manage pain; the disease is neither removed nor suppressed. Risk of disease progression and ovarian reserve damage continues. | Variable and time-sensitive. Reasonable for mild disease with good ovarian reserve and short-duration conception attempts. Delay can cost fertility in moderate or severe disease, or when endometriomas are present. Annual monitoring of ovarian reserve and cyst size is advised. | Coccia 2022: unoperated endometriomas can independently damage ovarian reserve over time; many patients with mild disease conceive without intervention, but these figures do not apply to already-infertile patients. |
Excision surgery: removing the disease
Laparoscopic excision surgery removes endometriosis lesions by sharp dissection down to healthy tissue. The surgeon cuts out the implant, including any disease below the visible surface, and sends the specimen to pathology for confirmation. Anatomy is restored. The pelvic environment that endometriosis disrupts is addressed directly.
The recurrence data after excision are the strongest available for any endometriosis treatment. Yeung and colleagues followed a cohort of teenagers through repeat laparoscopy at a mean of 23 months post-excision; zero histologic recurrence was found, and this was without any postoperative hormonal suppression. (Yeung et al., 2011)
Schippert and colleagues studied 206 patients with stage III/IV disease. Complete or partial symptom relief was achieved in 93.2%. Disease recurrence was documented in 21.8% over the follow-up period, a figure well below the recurrence rates reported after ablation. For patients seeking fertility, the postoperative pregnancy rate was 65.8% in those who wanted children, with laparoscopic access outperforming open surgery (74.3% versus 61.3%). (Schippert et al., 2020)
One nuance for patients with ovarian endometriomas: cystectomy can reduce ovarian reserve because healthy ovarian cortex is sometimes removed along with the cyst wall. Surgical technique and timing matter here. Wu and colleagues published a randomized controlled trial showing that cystectomy performed in the late luteal phase preserved AMH and ovarian reserve better than surgery at other cycle phases. (Wu et al., 2023) This is an area where the specific surgeon's approach and experience are load-bearing factors, not just the procedure category.
The RRM-preferred surgical approach is excision. See fertility-preserving surgery for a full discussion of technique, adhesion prevention, and the role of the excision surgeon in the restorative approach.
Ablation versus excision
Ablation uses heat or laser energy to destroy the visible surface of endometriosis implants. Excision cuts them out. The difference matters because endometriosis is not purely a surface disease. Implants have depth. Burning the surface leaves deeper tissue behind, and that tissue remains active, progresses, and produces symptoms.
The recurrence pattern makes this concrete. Reported recurrence and persistence after ablation are substantially higher than after complete excision, because surface treatment leaves deeper lesions behind. After complete excision, Yeung and colleagues found zero histologic recurrence at repeat surgery in teenagers, without postoperative hormonal suppression. (Yeung et al., 2011) That is not a marginal difference. It is the difference between a procedure that addresses the disease and one that treats its appearance.
For superficial peritoneal disease, clinical studies have found broadly similar short-term pain outcomes between excision and ablation. The advantage of excision is clearest for deep, infiltrating, or recurrent disease, where surface treatment leaves active lesions behind, and for confirming the diagnosis with tissue.
Ablation has a limited role: it may be used for very superficial peritoneal disease in specific circumstances, or where excision is not technically feasible. It is not a substitute for excision when the goal is complete disease clearance, lowest recurrence, and restored fertility.
Hormonal suppression: managing symptoms, not curing
Hormonal suppression medications, combined hormonal contraceptives, progestins, and GnRH agonists or antagonists, are the most commonly prescribed treatments for endometriosis. They are also the most commonly misunderstood. They manage symptoms. They do not remove or destroy endometriosis lesions.
There is no medication that treats endometriosis itself. This is not a fringe position. It reflects the biology: endometriosis is a disease of tissue implants. Medications cannot excise tissue. What they can do is create a hormonal environment that suppresses lesion activity, which reduces pain while the medication is being taken. When the medication stops, the disease is still there. Surrey's review of the GnRH agonist literature notes that symptoms commonly recur once therapy stops, citing a 53.4% recurrence rate at five years (originally reported by Waller and Shaw), with higher rates in severe disease. (Surrey, 2023)
The appropriate role for hormonal suppression is symptom control in patients who are not currently pursuing pregnancy, as a bridge before or after surgery, or where surgery is declined or unavailable. First-line medical management typically uses continuous combined hormonal contraceptives or progestins. GnRH agonists and antagonists are second-line options when first-line approaches fail; they carry additional risks including bone mineral density loss, which limits duration of use.
For couples pursuing fertility, hormonal suppression is incompatible with conception while in use, and offers no benefit after stopping beyond the window of treatment. It does not restore fertility. It delays more effective treatment. This is where the distinction between symptom masking and disease treatment becomes practically consequential: a woman managed on suppressive medications for years while her disease progresses and her ovarian reserve declines has not received treatment for her endometriosis. She has had her symptoms managed. Those are different things.
Dr. Whittaker describes it precisely: suppressive medications are hiding the symptoms, and hiding them very well. The disease underneath continues.
Does IVF treat endometriosis?
IVF does not treat endometriosis. This is a crucial distinction for any couple with endometriosis-associated infertility who is weighing their options.
IVF works by retrieving eggs, fertilizing them outside the body, and transferring embryos into the uterus. It does not remove endometriosis lesions. It does not restore the pelvic anatomy that endometriosis distorts. It does not address the inflammatory environment that compromises egg quality and implantation. After IVF, the disease is still present, and its consequences continue.
Endometriosis also makes IVF harder. In stage III/IV disease, oocyte yield is lower, implantation rates fall, clinical pregnancy rates decline, and cycle cancellation rates rise. Coccia and colleagues reviewed the evidence and noted that endometriomas reduce oocyte yield and raise the cancellation risk. (Coccia et al., 2022) IVF is harder precisely because the underlying disease it bypasses has already compromised the reproductive environment it is trying to work around.
The obstetric risk profile also warrants honest disclosure. IVF pregnancies carry elevated risks regardless of the indication. Almasi-Hashiani and colleagues analyzed 48 studies and found a 1.71-fold higher risk of preeclampsia with assisted reproductive technology compared to natural conception. (Almasi-Hashiani et al., 2019) The first published head-to-head comparison of RRM versus IVF outcomes found that RRM matched single-cycle IVF live-birth rates while producing fewer multiples, fewer preterm births, and fewer low-birth-weight babies. (Boyle et al., 2025)
The narrative that endometriosis requires IVF is built on the premise that the disease cannot be adequately treated and the body cannot achieve conception naturally. The excision data challenge that premise directly. For a full comparison, see NaProTechnology versus IVF and IVF alternatives.
When fertility is the goal
When fertility is the goal, the treatment hierarchy for endometriosis becomes sharper. The question is not just which option reduces pain, but which option creates the best conditions for conception.
Excision surgery does both. It removes the lesions that cause pain and disrupts the anatomical distortion, inflammatory environment, and ovarian reserve threats that reduce fertility. Schippert and colleagues documented a 65.8% postoperative pregnancy rate in stage III/IV patients pursuing fertility. (Schippert et al., 2020) This is not the outcome of a procedure that merely managed symptoms. It is the outcome of disease removal.
For patients with ovarian endometriomas, the surgical decision is more nuanced. Cystectomy can damage ovarian reserve. Timing the surgery to the late luteal phase appears to preserve reserve better than other cycle phases, based on a randomized controlled trial. (Wu et al., 2023) The decision about whether and when to operate on an endometrioma in a patient pursuing fertility requires an experienced excision surgeon who understands the reserve implications of the specific technique.
Postoperative care in the restorative approach does not end at the operating room. NaProTechnology and RRM clinicians use cycle charting and timed hormonal assessment after surgery to identify and address any remaining contributors to subfertility: luteal phase defects, ovulatory dysfunction, cervical mucus quality, or hormonal imbalances that surgery alone does not correct. This is where the restorative approach differs from a surgical-only plan.
Both partners are evaluated. Male factor is the sole or primary cause of infertility in approximately 20% of couples and a contributing factor in another 30-40%. A couple presenting with endometriosis-associated infertility may also have a male-factor contributor that will not be resolved by excision alone. The full workup evaluates both.
For detailed guidance on fertility-preserving surgical technique and what to expect from a restorative approach after surgery, see fertility-preserving surgery and NaProTechnology versus IVF.
How to choose your treatment
The treatment decision for endometriosis follows from two questions: Is the goal symptom relief, fertility, or both? And what does the patient want to do with the disease itself, remove it or manage it?
A few practical considerations help organize the path:
- If symptoms are severe or refractory to non-surgical management, excision surgery is the appropriate next step. It offers the highest probability of durable symptom relief and the lowest recurrence rates in the published literature. The surgeon's experience with excision, not just laparoscopy generally, determines the quality of the outcome.
- If fertility is the goal and the disease is confirmed or strongly suspected (especially deep infiltrating disease or symptomatic stage III/IV), excision removes the biological barriers to conception that hormonal suppression and IVF leave in place.
- If hormonal suppression is being considered, clarify the goal: it is appropriate for symptom control when the patient is not pursuing pregnancy. It is not a substitute for surgery in patients who want the disease removed, and it is not a fertility treatment.
- If IVF has been recommended as the primary treatment for endometriosis-associated infertility, it is worth asking what the plan is for the disease itself. IVF does not address it. The excision question should come first.
- If an endometrioma is present, timing the surgery to the late luteal phase may better preserve ovarian reserve than other phases. The surgical approach to the endometrioma should be discussed in detail with the surgeon before proceeding.
- Hysterectomy should only be considered last, in patients with severe, refractory symptoms who have completed childbearing, and only with concurrent excision of all extrauterine disease. It is not a cure for endometriosis and should never be framed as one.
To find an RRM clinician experienced in excision surgery and restorative fertility care, visit rrmacademy.org/providers/. Before or after a surgical consultation, the endometriosis symptom self-survey can help organize your symptom history and flag patterns worth raising with a clinician. For a comprehensive overview of the disease itself, see the endometriosis condition guide.
Continue exploring
References
- Yeung P, Sinervo K, Winer W, Albee RB. Complete laparoscopic excision of endometriosis in teenagers: is postoperative hormonal suppression necessary?. Fertility and Sterility. 2011;95(6):1909-1912.e1. doi:10.1016/j.fertnstert.2011.02.037. PMID 21420081. View in RRM Library
- Schippert C, Witte Y, Bartels J, Garcia-Rocha GJ, Jentschke M, Hillemanns P, Kundu S. Reproductive capacity and recurrence of disease after surgery for moderate and severe endometriosis: a retrospective single center analysis. BMC Women's Health. 2020;20(1):134. doi:10.1186/s12905-020-01016-3. PMID 32660473. View in RRM Library
- Surrey ES. GnRH agonists in the treatment of symptomatic endometriosis: a review. F&S Reports. 2023;4(2 Suppl):40-45. doi:10.1016/j.xfre.2022.11.009. PMID 37223763. View in RRM Library
- Wu Q, Yang Q, Lin Y, Wu L, Lin T. The optimal time for laparoscopic excision of ovarian endometrioma: a prospective randomized controlled trial. Reproductive Biology and Endocrinology. 2023;21(1):59. doi:10.1186/s12958-023-01109-2. PMID 37370122. View in RRM Library
- Coccia ME, Nardone L, Rizzello F. Endometriosis and infertility: a long-life approach to preserve reproductive integrity. International Journal of Environmental Research and Public Health. 2022;19(10):6162. doi:10.3390/ijerph19106162. PMID 35627698. View in RRM Library
- Almasi-Hashiani A, Omani-Samani R, Mohammadi M, Amini P, Navid B, Alizadeh A, et al. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy and Childbirth. 2019;19(1):149. doi:10.1186/s12884-019-2291-x. PMID 31046710. View in RRM Library
- Boyle P, Toth A, Minjeur M, Turczynski C. Restorative reproductive medicine (RRM) outcomes compared to in-vitro fertilization (IVF) for the treatment of infertility: a retrospective evaluation of a 2019 clinic cohort compared to one cycle of IVF. Journal of Restorative Reproductive Medicine. 2025;1. doi:10.63264/gejytw70. View in RRM Library
- Whittaker NM. Endometriosis Masterclass. RRM Academy. (Clinician educational reference.)
Frequently Asked Questions
What is the best treatment for endometriosis?
The best treatment depends on the goal, but the most important starting point is this: only excision surgery removes the disease itself. Every other option either masks symptoms, bypasses the disease, or manages the consequences. For patients with confirmed or strongly suspected endometriosis, particularly deep infiltrating or symptomatic stage III/IV disease, laparoscopic excision surgery removes lesions, restores anatomy, and offers the lowest published recurrence rates. For symptom control in patients not pursuing pregnancy, hormonal suppression is an appropriate bridge, not a cure. For fertility, excision addresses the underlying disease in a way that hormonal management and IVF do not. See the endometriosis guide for a full overview of the condition. Consult an RRM clinician for guidance specific to your situation.
Is excision better than ablation?
The evidence consistently favors excision over ablation. Ablation destroys the visible surface of endometriosis implants using heat or laser. It does not remove disease below the surface, and surface-only treatment leaves deeper tissue active. Recurrence and persistence after ablation are substantially higher than after complete excision, even with postoperative hormonal suppression. After complete excision, Yeung and colleagues found zero histologic recurrence in teenagers at repeat laparoscopy. (Yeung et al., 2011) The single head-to-head trial was underpowered and should not be read as proof of equivalence. When complete disease clearance and low recurrence are the goals, excision is the appropriate approach. Consult an RRM clinician for guidance specific to your situation.
Can endometriosis be cured?
Complete laparoscopic excision, when performed thoroughly by an experienced surgeon, achieves very low recurrence rates and durable symptom relief for many patients. Whether that constitutes a cure depends on how the term is defined. Yeung and colleagues found zero histologic recurrence at repeat surgery in teenagers following complete excision without postoperative hormones. (Yeung et al., 2011) Hormonal suppression, hysterectomy, ablation, and IVF do not cure endometriosis. They manage symptoms or bypass the problem while the disease remains. The honest answer: thorough excision offers the best disease-clearance outcomes available. The quality of the outcome depends substantially on the surgeon's training and technique. Consult an RRM clinician for guidance specific to your situation.
Does birth control treat endometriosis?
Hormonal contraceptives, including combined pills, progestins, and GnRH agonists, manage endometriosis symptoms by suppressing the hormonal environment that drives lesion activity. They do not remove or destroy lesions. The disease remains in place while medications are being taken, and symptoms typically return after stopping. Surrey and colleagues documented a 53.4% symptom recurrence rate at five years following GnRH therapy, with higher rates in severe disease. (Surrey, 2023) These medications have an appropriate role in symptom control when surgery is not indicated or not yet planned. They are not a substitute for excision and are not a fertility treatment. For patients pursuing pregnancy, hormonal suppression also suppresses ovulation and is incompatible with conception. Consult an RRM clinician for guidance specific to your situation.
Do I need IVF if I have endometriosis?
In many cases, the more useful question is whether the endometriosis itself has been treated, not whether IVF is the next step. IVF does not remove endometriosis or address the pelvic environment the disease creates. Disease and pain persist after IVF. Advanced-stage endometriosis also reduces IVF performance: oocyte yield falls, implantation rates decline, and cancellation rates rise. (Coccia et al., 2022) Schippert and colleagues reported a 65.8% postoperative pregnancy rate in stage III/IV patients following excision surgery. (Schippert et al., 2020) For many couples with endometriosis-associated infertility, excision surgery followed by a restorative fertility workup is the more appropriate first path. Consult an RRM clinician for guidance specific to your situation.
Will surgery help me get pregnant?
For many couples with endometriosis-associated infertility, excision surgery improves the conditions for conception by removing lesions, restoring anatomy, and addressing the pelvic inflammatory environment the disease creates. Schippert and colleagues followed 206 stage III/IV patients and found a 65.8% postoperative pregnancy rate among those pursuing fertility. Laparoscopic access outperformed open surgery (74.3% versus 61.3%). (Schippert et al., 2020) Both partners are evaluated in the restorative approach because male factor contributes to infertility in a meaningful share of couples with endometriosis as the presenting diagnosis. After surgery, cycle-charting-guided hormonal assessment identifies any remaining contributors: luteal phase defects, ovulatory dysfunction, or hormonal imbalances that excision alone does not correct. See fertility-preserving surgery for full detail. Consult an RRM clinician for guidance specific to your situation.
Does endometriosis come back after surgery?
Recurrence depends heavily on the surgical approach. After ablation, recurrence and persistence are substantially higher than after complete excision, even with postoperative hormonal suppression. After thorough excision, the data are substantially better. Yeung and colleagues found zero histologic recurrence at repeat laparoscopy in teenagers following complete excision without postoperative hormones. (Yeung et al., 2011) Schippert and colleagues documented 21.8% recurrence in stage III/IV patients at follow-up. (Schippert et al., 2020) Surgeon experience and completeness of excision are the primary variables. The question to ask any surgical candidate is not just whether they perform laparoscopy, but whether they perform complete excision down to healthy tissue. Consult an RRM clinician for guidance specific to your situation.
This content is for educational and reference purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified clinician about your specific situation.